NCT01861899 is a clinical trial of SI-LOK in Joint Dysfunction, sponsored by Globus Medical Inc.

Who is sponsoring NCT01861899?

NCT01861899 is sponsored by Globus Medical Inc.

What drugs are being tested in NCT01861899?

Interventions in NCT01861899: SI-LOK.

What condition does NCT01861899 study?

NCT01861899 studies Joint Dysfunction.

Is NCT01861899 still recruiting?

NCT01861899 is currently completed. Last updated 11 September 2020.

Last reviewed 2020-09-11 · How we verify

NCT01861899

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Treatment of Sacroiliac Dysfunction With SI-LOK® Sacroiliac Joint Fixation SI-SI-LOK

Completed Last updated 11 September 2020

What this trial tests

trial testing SI-LOK in Joint Dysfunction in 46 participants. Completed in 11 April 2019.

Timeline

2 May 2013

Primary endpoint
5 July 2018

11 April 2019

Quick facts

Lead sponsor	Globus Medical Inc
Status	Completed
Study type	OBSERVATIONAL
Enrollment	46
Start date	2 May 2013
Primary completion	5 July 2018
Estimated completion	11 April 2019
Sites	1 location across United States

Drugs / interventions tested

SI-LOK

Conditions studied

Joint Dysfunction — all drugs for Joint Dysfunction →

Sponsor

Globus Medical Inc — full company profile →

Who can join

Adults 21 to 70, any sex, with Joint Dysfunction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study is to gather clinical data on SI-LOK® for the treatment of sacroiliac joint dysfunction. The purpose of this prospective study is to evaluate clinical and radiographic outcomes, intra-operative parameters, patient satisfaction and work status following a procedure using SI-LOK® for treatment of sacroiliac joint dysfunction with a minimum of three screws.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Globus Medical Inc trials

Trials by the same sponsor.

NCT06298812 — REFLECT Scoliosis System Post Approval Study · NA · recruiting
NCT04088383 — Amnios™ RT Outcomes Study · NA · completed
NCT03371316 — Preliminary Investigation of ViaShield™ Amnion Patch as an Anti-Adhesive Barrier in Hemicraniectomies · NA · withdrawn
NCT03162666 — Patient Outcomes Using an Expandable Spacer · withdrawn
NCT02184520 — A Prospective Randomized Postmarket Clinical Study of the TRANSITION Stabilization System · NA · terminated

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01861899 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Globus Medical Inc
Last refreshed: 11 September 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01861899.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing